# Insights into germline predisposition to pediatric lymphoid malignancies

## TL;DR

This paper explores how inherited genetic factors can increase the risk of lymphoid cancers in children and highlights the importance of understanding these genetic predispositions for better clinical care.

## Contribution

The paper provides a comprehensive review of genetic predispositions to pediatric lymphoid malignancies, emphasizing biological mechanisms and clinical implications.

## Key findings

- Genetic predispositions to lymphoid malignancies involve genes critical for lymphocyte development and DNA repair.
- Pathogenic variants in these genes are linked to increased cancer risk and other non-oncologic manifestations.
- Germline testing is increasingly recognized as vital for understanding and managing pediatric lymphoid malignancies.

## Abstract

Hematopoietic malignancies (HM) represent the most common form of pediatric cancer with lymphoid malignancies being the predominant subtype in kids. The majority of lymphoid malignancies are proposed to occur sporadically with environmental, infectious and inflammatory triggers impacting oncogenesis in ways that are not yet fully understood. With the increased adoption of germline genetic testing in children with cancer, genetic predisposition to lymphoid malignancies is now recognized as an important aspect of clinical care and research. Pathogenic variants in genes important for lymphocyte development, including cell differentiation, DNA recombination, recognition and repair of DNA damage, apoptosis, RNA processing, and intracellular signaling all converge on an increased risk for lymphoid malignancies. Herein, we review several genetic predispositions to lymphoid malignancies with a focus on the underlying biological defect, as well as the associated oncologic and non-oncologic manifestations.